European markets slightly higher ahead of expected rate cut from the European Central Bank

European markets slightly higher ahead of expected rate cut from the European Central Bank


European markets moved higher at the start of the session, as regional investors await this year’s final monetary policy decision from the European Central Bank (ECB).

The pan-European Stoxx 600 index was up 0.08% by 9:00 a.m. London time, with all major bourses and most sectors trading in the green. Oil and gas stocks added 0.92%, while media stocks dipped 0.28%.

The central bank is heading for its final interest rate cut of the year on Thursday, with economists expecting a 25-basis-point rate cut rather than the “jumbo” 50-basis-point move that was previously expected. The ECB is also due to release its quarterly macroeconomic projections on growth and inflation.

The Swiss National Bank also announced latest monetary policy decision Thursday, cutting rates by 50 basis points.

It comes as traders continue to digest the latest inflation data out of the U.S. The figures showed that consumer prices rose 0.3% month on month and grew at a 12-month rate of 2.7%, in line with economists’ estimates.

The producer price index report is due Thursday. The prints mark the last major economic data releases before the Federal Reserve’s policy meeting next week.

Traders are still betting that the Fed will cut rates; Fed funds futures are pricing in a more-than 98% likelihood that the central bank lowers rates at that meeting, according to CME’s FedWatch Tool.

Overnight, Asia-Pacific markets were mostly higher following post-inflation data gains on Wall Street that saw the Nasdaq Composite top the 20,000 threshold, posting an all-time high and a closing record. U.S. stock futures slid Thursday morning.



Source

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial
World

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial

Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning. Eli Lilly‘s stock […]

Read More
Sam Altman defends AI resource usage: Water concerns ‘fake,’ and ‘humans use energy too’
World

Sam Altman defends AI resource usage: Water concerns ‘fake,’ and ‘humans use energy too’

OpenAI CEO Sam Altman on Friday defended the resource demands of artificial intelligence, calling concerns about data centers’ water use “fake” and comparing the energy used by AI systems to that of humans. Altman was speaking on the sidelines of the India AI Impact summit in an interview with The Indian Express when he was […]

Read More
CNBC Daily Open: New Trump tariffs are up after U.S. Supreme Court strikes some down
World

CNBC Daily Open: New Trump tariffs are up after U.S. Supreme Court strikes some down

U.S. President Donald Trump speaks during the National Governors Association Evening Dinner and Reception in the East Room of the White House on February 21, 2026 in Washington, DC, U.S. Al Drago | Getty Images News | Getty Images The U.S. Supreme Court on Friday struck down much of President Donald Trump’s “reciprocal” tariffs, which […]

Read More